Dr. Vikas Singh is a distinguished Consultant Urologist in Indore, specializing in the most advanced surgical treatments for Benign Prostatic Hyperplasia (BPH). He is highly skilled in performing ThuFLEP (Thulium Fiber Laser Enucleation of Prostate) and HoLEP (Holmium Laser Enucleation of Prostate)—cutting-edge laser techniques that represent the gold standard for treating even very large prostates. These procedures offer a true alternative to traditional open prostatectomy, providing the same excellent outcomes but with minimal invasiveness, significantly less bleeding, and remarkably faster recovery. Practicing at Kokilaben Dhirubhai Ambani Hospital with access to the latest laser technology, Dr. Singh ensures patients receive world-class care with optimal functional results and minimal complications. We maintain complete transparency about treatment costs and facilitate smooth insurance processing for our patients throughout Central India.
Consultant Surgeon at Kokilaben Dhirubhai Ambani Hospital, Indore, equipped with advanced Thulium and Holmium laser systems.
Extensive expertise in advanced endoscopic procedures with hundreds of successful laser enucleations performed.
Capable of treating prostates from 30 grams to over 200 grams with equal precision and safety.
Unlike vaporization techniques that remove tissue gradually, enucleation completely removes the obstructing adenoma (inner prostate tissue) as intact lobes, similar to open surgery but performed endoscopically through the urethra. This ensures complete removal of all obstructing tissue in a single procedure, regardless of prostate size.
Both techniques achieve the same goal but use different laser wavelengths. Thulium Fiber Laser (ThuFLEP) offers continuous-wave energy with superior hemostasis and smoother cutting, while Holmium laser (HoLEP) uses pulsed energy and has the longest track record. Dr. Singh selects the optimal technology based on prostate characteristics and available equipment.
Laser enucleation is particularly beneficial for very large prostates (>80 grams), patients on blood thinners who cannot stop anticoagulation, those with cardiac conditions making open surgery risky, and anyone seeking the most durable long-term solution with minimal recovery time.
Under anesthesia, Dr. Singh uses the laser fiber through a specialized endoscope to meticulously separate the enlarged prostate adenoma from its outer capsule—like peeling an orange. The entire obstructing tissue is freed in intact lobes, which are then pushed into the bladder for the next step.
A specialized device called a morcellator is introduced to safely cut the enucleated tissue into small fragments that can be removed through the scope. This tissue is sent for pathological examination to rule out any incidental prostate cancer, providing an additional diagnostic benefit.
The laser’s precise cutting ability and excellent hemostasis mean minimal blood loss—even patients on blood thinners can safely undergo the procedure. The technique preserves surrounding structures, protecting urinary continence mechanisms and erectile function.
Removes all obstructing adenoma, providing the most durable long-term results—reoperation rates under 2% even after 10+ years.
Virtually bloodless surgery, safe even for patients who cannot stop blood thinners or have bleeding disorders.
Hospital discharge within 1-2 days, catheter removed within 24-48 hours, return to normal activities within 2 weeks.
Equally effective for prostates of 50 grams or 250 grams—the technique scales with prostate size without increasing risk.
Schedule a private, confidential consultation with Dr. Singh in Indore.
Both techniques achieve identical outcomes—complete enucleation of the prostate adenoma. The difference lies in the laser wavelength used. Thulium Fiber Laser (ThuFLEP) offers continuous-wave energy with potentially superior hemostasis and smoother tissue dissection, while Holmium laser (HoLEP) uses pulsed energy and has over 25 years of proven long-term data. Dr. Singh is proficient in both techniques and selects based on equipment availability and individual prostate characteristics. From a patient outcome perspective, both deliver excellent results.
Laser enucleation is beneficial for virtually any prostate size but becomes particularly advantageous for prostates over 80 grams. At this size, conventional TURP becomes less effective and riskier, while open surgery was traditionally the only option. ThuFLEP/HoLEP provides a minimally invasive alternative that works equally well whether your prostate is 80 grams or 250 grams, with the same excellent recovery profile.
Yes, this is one of the major advantages of laser enucleation. The superior hemostatic properties of both Thulium and Holmium lasers make these procedures remarkably safe even for patients who cannot stop anticoagulation. Many patients with cardiac stents, atrial fibrillation, or previous strokes who require continuous blood thinning can safely undergo ThuFLEP or HoLEP without interrupting their anticoagulation therapy, after careful coordination with their cardiologist.
The side effect profile is similar to other prostate procedures but often less severe. Most patients experience temporary urinary urgency and frequency for 2-4 weeks as the large enucleation cavity heals. Retrograde ejaculation (dry climax) occurs in approximately 75-80% of patients but doesn’t affect sexual pleasure or erectile function. Urinary incontinence is rare (<5%) and usually temporary, resolving with pelvic floor exercises. Urethral stricture or bladder neck contracture occurs in less than 5% of cases and can be managed if it develops.
The recovery difference is dramatic. Open prostatectomy requires a large incision, results in significant blood loss often requiring transfusion, involves 5-7 days hospitalization, 7-10 days of catheterization, and 6-8 weeks until full recovery. In contrast, ThuFLEP/HoLEP involves no incision, minimal bleeding, 1-2 days in hospital, catheter removal within 24-48 hours, and return to normal activities within 2 weeks. Patients achieve the same excellent long-term outcomes with dramatically reduced surgical trauma and recovery time.
One of the most significant advantages of complete enucleation is durability. Because the entire adenoma (obstructing tissue) is removed down to the surgical capsule, there’s minimal tissue left to regrow. Long-term studies show reoperation rates of less than 2% even 10-15 years after HoLEP, making it the most durable surgical option available. This is superior to TURP (10-15% reoperation rate at 10 years) and far better than medical management.
Yes, laser enucleation procedures are recognized as medically necessary surgical treatments for BPH and are covered by most major health insurance policies in India, including corporate plans, government schemes like Ayushman Bharat, and ECHS. Our administrative team has extensive experience with insurance pre-authorization for these advanced procedures and will guide you through the documentation process to ensure smooth approval and cashless treatment whenever possible.
The leading center for advanced, compassionate urological care and treatment in Indore, Madhya Pradesh.
